CA Stock MarketDetailed Quotes
WAVE Waverley Pharma Inc
- 0.015
- 0.0000.00%
15min DelayTrading Dec 18 16:00 ET
810.00KMarket Cap-0.38P/E (TTM)
0.000High0.000Low0Volume0.000Open0.015Pre Close0.00Turnover0.03552wk High0.00%Turnover Ratio54.00MShares0.01052wk Low-0.04EPS TTM203.27KFloat Cap0.600Historical HighLossP/E (Static)13.55MShs Float0.010Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM-0.41P/B1Lot Size--Div YieldTTM
Waverley Pharma Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -33.81%-112.15K | -330.74%-1.02M | -155.33%-482.41K | -27.56%-267.92K | -1,584.13%-186.97K | -156.14%-83.82K | 70.32%-237.06K | 15.22%-188.94K | -69.03%-210.02K | 103.62%12.6K |
| Net income from continuing operations | 22.21%-264.13K | -234.91%-2.22M | -543.21%-1.33M | -154.67%-309.96K | -902.23%-240.96K | -9.19%-339.56K | 16.63%-664.08K | 22.65%-207.33K | 41.27%-121.71K | 83.68%-24.04K |
| Operating gains losses | 142.13%6.02K | ---- | ---- | -86.59%8.17K | 99.74%-348 | -98.20%2.49K | ---- | ---- | --60.94K | ---134.31K |
| Depreciation and amortization | -75.51%26.1K | 100.98%426.28K | -0.13%106.57K | 192.53%106.57K | 208.33%106.57K | 209.76%106.57K | 201.91%212.1K | 100.21%106.71K | 225.31%36.43K | 1,127.85%34.56K |
| Asset impairment expenditure | ---- | --1.01M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Deferred tax | ---- | 83.57%-48.95K | ---- | ---- | ---- | ---- | ---297.99K | ---63.33K | ---- | ---- |
| Other non cashItems | 176.87%32.44K | 182.26%46.96K | ---575 | ---- | ---- | --11.72K | 447.84%16.64K | ---- | ---- | ---- |
| Change In working capital | -17.59%120.74K | -129.75%-151.94K | -567.04%-174.13K | -247.55%-72.27K | -138.17%-52.06K | -49.15%146.51K | 663.64%510.75K | 239.78%37.28K | -34.19%48.98K | 166.88%136.39K |
| -Change in receivables | -88.43%7.22K | -79.95%55.2K | 91.49%-5.09K | -168.38%-96.91K | 603.18%94.77K | -65.31%62.43K | 211.89%275.38K | -522.36%-59.79K | 262.76%141.72K | 106.58%13.48K |
| -Change in inventory | 101.18%633 | -79.23%60.89K | 4,687.07%89.77K | -30.30%63.02K | 7.05%-38.2K | -121.85%-53.7K | 554.35%293.1K | 98.30%-1.96K | -58.43%90.42K | 78.10%-41.1K |
| -Change in prepaid assets | -3.90%77.13K | 34.43%-18.92K | 20.63%-195.04K | -69.95%71.62K | 151.33%24.24K | 211.48%80.26K | -390.33%-28.86K | -1,683.63%-245.75K | 695.28%238.34K | 17.68%-47.22K |
| -Change in payables and accrued expense | -37.85%35.75K | -762.80%-249.11K | -118.50%-63.77K | 73.90%-109.99K | -162.90%-132.87K | 135.20%57.52K | -112.78%-28.87K | 316.10%344.78K | -390.25%-421.5K | -14.09%211.22K |
| Interest paid (cash flow from operating activities) | -188.74%-33.32K | -439.70%-78.18K | ---30.21K | ---- | ---- | ---11.54K | -571.85%-14.49K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -33.81%-112.15K | -330.74%-1.02M | -155.33%-482.41K | -27.56%-267.92K | -1,584.13%-186.97K | -156.14%-83.82K | 70.32%-237.06K | 15.22%-188.94K | -69.03%-210.02K | 103.62%12.6K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -226.63K | |||||||
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---226.63K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | ---- | ---- | ---- | ---226.63K | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 33.02%113.24K | 114.02%940.33K | 19.01%503.87K | 153.13%85.13K | 97.60%439.37K | 90.40%423.37K | 203.16K | -26.92K | ||
| Net issuance payments of debt | 33.02%113.24K | 114.02%940.33K | 154.78%503.87K | ---- | ---- | 153.13%85.13K | 97.60%439.37K | -11.06%197.77K | --428.77K | ---26.92K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 33.02%113.24K | 114.02%940.33K | 19.01%503.87K | 23.86%251.63K | 470.41%99.7K | 153.13%85.13K | 97.60%439.37K | 90.40%423.37K | --203.16K | ---26.92K |
| Net cash flow | ||||||||||
| Beginning cash position | -60.38%53.02K | -15.38%133.8K | -74.95%31.56K | -63.98%47.85K | -5.79%135.12K | -15.38%133.8K | -77.75%158.12K | -8.89%125.99K | -48.80%132.85K | -77.24%143.42K |
| Current changes in cash | -17.00%1.09K | -232.19%-80.78K | 174.78%21.45K | -137.39%-16.29K | -509.45%-87.27K | 112.04%1.32K | 95.78%-24.32K | 1,615.92%7.81K | 94.48%-6.86K | 95.88%-14.32K |
| Effect of exchange rate changes | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| End cash Position | -59.95%54.11K | -60.38%53.02K | -60.38%53.02K | -74.95%31.56K | -63.98%47.85K | -5.79%135.12K | -15.38%133.8K | -15.38%133.8K | -8.89%125.99K | -48.80%132.85K |
| Free cash from | -33.81%-112.15K | -330.74%-1.02M | -155.33%-482.41K | -27.56%-267.92K | -1,584.13%-186.97K | -156.14%-83.82K | 70.32%-237.06K | 15.22%-188.94K | -69.03%-210.02K | 103.62%12.6K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data